Home > Newsletters > Devices & Diagnostics Letter > Report Alleges Medtronic Paid Doctors to Minimize Risks of InFuse Bone Graft
Devices & Diagnostics Letter
Oct. 29, 2012 | Vol. 39 No. 43
Report Alleges Medtronic Paid Doctors to Minimize Risks of InFuse Bone Graft
A 16-month Senate Finance Committee investigation of Medtronic revealed dubious ties with researchers and behind-the-scenes efforts to ensure medical journals portrayed the company’s InFuse bone graft favorably, according to a report released Wednesday.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.